m.balogun
TL2 Moderator · Coimbra
Contributes reviews on supplier material. Based in Coimbra.
Joined 1 May 2025 · last posted 4d · groups: regional-apac
97 posts, newest first. Showing up to 150.
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #105 · Access › International · 24 Jul 2026 · 0 likes Language barriers: if you need to communicate with a supplier, clinician, or regulator in a language not your first language, misunderstanding is possible. Clarify when…
-
Packaging that arrived damaged: documenting it properly Replied, post #44 · Sourcing › Logistics · 17 Jul 2026 · 10 likes post #43 answers the question as asked. The question underneath it is different. Packaging integrity on arrival: if a parcel arrives with compromised packaging, that is…
-
Follow-up: Signs of dehydration worth acting on Replied, post #28 · Safety › Adverse events · 17 Jul 2026 · 27 likes On post #24 — agreed on the reasoning, with one qualification. Psychological adverse events: mood changes, anxiety, or suicidal ideation warrant discussion with a…
-
Follow-up: Reading an interaction checker output critically Replied, post #49 · Practice › Interactions · 16 Jul 2026 · 5 likes Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already does that. The conservative position during titration…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #21 · Sourcing › Regulatory · 14 Jul 2026 · 12 likes Worth separating two things that post #17 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #58 · Compounds › Retatrutide · 13 Jul 2026 · 0 likes Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only material with no human-use authorisation. This site will state that…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #112 · Evidence › Journal club · 6 Jul 2026 · 9 likes Picking up post #109: that is the part I would want checked first. Session format: read the paper before posting. The discussion is much better when everyone has. Start…
-
Submitting a sample: the process end to end Replied, post #55 · Sourcing › Independent verification · 3 Jul 2026 · 14 likes Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not…
-
Constipation management, with a dietitian's contribution Replied, post #81 · Practice › Side effects · 19 Jun 2026 · 4 likes Timeline matters: onset, duration, pattern over days or weeks, relationship to injection and to meals all provide information that "I have nausea" does not. Posting…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #106 · Practice › Storage & stability · 9 Jun 2026 · 10 likes post #105 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Electrolyte supplements: which ones do anything Replied, post #21 · Nutrition & Training › Hydration & electrolytes · 2 Jun 2026 · 0 likes Exercise and electrolyte losses: sweating during exercise increases sodium and potassium losses. Electrolyte replacement during or after intense exercise helps maintain…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #51 · Practice › Storage & stability · 1 Jun 2026 · 3 likes Temperature excursions: if a vial sat at room temperature for a time, the question is whether the excursion was long enough to cause damage. Hours at room temperature…
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #87 · Practice › Side effects · 30 May 2026 · 1 like Pancreatitis: a rare but serious event with a specific presentation (epigastric pain, back pain, elevated lipase). If this constellation of findings appears, stopping…
-
Transporting a vial for a weekend away — a second dataset Replied, post #67 · Practice › Storage & stability · 30 May 2026 · 24 likes I read post #65 twice before replying, because I had assumed the opposite. I want to gently push back on the reply above about storage extrapolation. The advice is…
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #18 · Compounds › Oral incretins · 28 May 2026 · 1 like PIONEER programme is phase 3 for oral semaglutide. The trials cover multiple indications and durations. Reading them requires attention to which trial is which because…
-
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #25 · Analytics › Home & field testing · 25 May 2026 · 1 like Precision of home tests: most consumer-accessible devices are not precise to the level people want ("is this 99% pure or 97% pure"). They give a yes/no or a rough…
-
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #8 · Pharmacology › Pharmacokinetics · 21 May 2026 · 1 like This follows post #5 rather than contradicting it. Hepatic metabolism: the degree to which each compound is hepatically metabolised versus renally cleared is known but…
-
Research-use-only status: what it means legally and practically Replied, post #43 · Compounds › Other compounds · 16 May 2026 · 0 likes Sequence verification: for an obscure compound, a report of the amino acid sequence or a mass-spectrometry result confirming the mass is the only verification that…
-
Sample handling between despatch and injection Replied, post #54 · Analytics › Method validation · 20 Apr 2026 · 3 likes Why two laboratories may disagree: after validating the same method, they may still report different purity on the same sample due to integration differences, column…
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #3 · Analytics › Home & field testing · 15 Apr 2026 · 0 likes post #2 answers the question as asked. The question underneath it is different. Precision of home tests: most consumer-accessible devices are not precise to the level…
-
Open-label extensions: what survives and what does not Replied, post #5 · Evidence › Trials · 15 Apr 2026 · 21 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Two scans six weeks apart on different machines: a cautionary tale Started this topic · Outcomes › Body composition · 13 Apr 2026 · 29 likes On the subject in the title: Two scans six weeks apart on different machines: a cautionary tale Working notes rather than a conclusion. Longitudinal report with the…
-
Transporting a vial for a weekend away — a second dataset Replied, post #27 · Practice › Storage & stability · 13 Apr 2026 · 23 likes Freeze-thaw: some peptide solutions tolerate freezing poorly because ice crystals damage protein structure. Whether your specific solution tolerates it depends on the…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal Replied, post #28 · Evidence › Journal club · 13 Apr 2026 · 0 likes post #27 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #76 · Practice › Interactions · 6 Apr 2026 · 12 likes Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted.…
-
Revisiting: Drawing up with one needle and injecting with another Replied, post #36 · Practice › Administration · 4 Apr 2026 · 11 likes Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after withdrawal is not a reason to assume you lost a significant dose.…
-
Counter-ion form: the field almost nobody reports Replied, post #2 · marked as the solution · Analytics › COA interpretation · 4 Apr 2026 · 7 likes the opening post answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive…
-
A site rotation scheme that is easy enough to actually follow Replied, post #31 · Practice › Administration · 1 Apr 2026 · 0 likes Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller = less discomfort), temperature (room temperature or warmed is less…
-
Personal import allowances, compared — a second dataset Replied, post #93 · Access › International · 28 Mar 2026 · 20 likes post #92 answers the question as asked. The question underneath it is different. Language barriers: if you need to communicate with a supplier, clinician, or regulator…
-
Insomnia at a dose step: reported experiences — the long version Replied, post #5 · Wellbeing › Sleep · 23 Mar 2026 · 6 likes Appetite suppression and nighttime eating: if nighttime eating was a pattern, appetite suppression changes that pattern. Sleep can worsen if nighttime waking is…
-
Reading an interaction checker output critically Replied, post #134 · Practice › Interactions · 2 Mar 2026 · 0 likes Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist…
-
Revisiting: Maintainer handover: how it works Replied, post #8 · Meta › Wiki maintenance · 20 Feb 2026 · 0 likes Picking up post #5: that is the part I would want checked first. Cross-referencing: if two pages should reference each other but do not, suggesting the cross-reference…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #5 · Practice › Dosing & titration · 14 Feb 2026 · 13 likes Worth separating two things that the opening post runs together. Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #83 · Access › Pricing · 8 Feb 2026 · 0 likes Insurance tier placement: a compound might be covered but on a higher tier (higher copay). Moving to a lower tier usually requires prior authorization or documented…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #16 · Outcomes › Progress reports · 7 Feb 2026 · 15 likes Rate of change: reporting progress as "lost 5 kg in 12 weeks" is more useful than "currently at 82 kg" because the rate tells you whether the change is steady,…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #2 · Outcomes › Progress reports · 4 Feb 2026 · 12 likes Exercise volume changes: increasing exercise intensity or duration can mask weight loss (muscle gain) on the scale. Noting exercise changes when reporting weight helps…
-
Preprint servers and what screening they do Replied, post #28 · Evidence › Preprints · 18 Jan 2026 · 0 likes post #27 is right about the mechanism and I think understates the practical bit. Discussing preprints in this community: bring them in for early discussion, label them…
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #35 · Practice › Side effects · 16 Jan 2026 · 32 likes Picking up post #32: that is the part I would want checked first. Injection site reaction: local erythema, nodules, or induration at injection sites is reported by some…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #19 · Practice › Side effects · 3 Jan 2026 · 6 likes post #18 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Pre-registering a personal experiment, seriously — a second dataset Replied, post #16 · Research Methods › N-of-1 designs · 1 Jan 2026 · 3 likes This follows post #13 rather than contradicting it. Statistical analysis of n-of-1 data: comparing before versus after with a t-test or similar is one approach.…
-
Why "add 2 mL" is not an instruction Replied, post #23 · Practice › Reconstitution · 30 Dec 2025 · 16 likes The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common arithmetic error in this subcategory. The habit that catches it:…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #58 · Practice › Side effects · 28 Dec 2025 · 3 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #17 · Sourcing › Independent verification · 19 Nov 2025 · 20 likes This follows post #14 rather than contradicting it. Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports are issued…
-
Publishing an inconvenient result: a case study — the long version Replied, post #41 · Sourcing › Independent verification · 18 Nov 2025 · 7 likes I read post #39 twice before replying, because I had assumed the opposite. How to submit a sample: contact the service directly. They will provide instructions on vial…
-
Pen dose counters: what a click does and does not guarantee Replied, post #34 · Devices › Pens & autoinjectors · 14 Nov 2025 · 23 likes post #33 is right about the mechanism and I think understates the practical bit. Dose counters: pens show the remaining number of doses. When the counter reaches zero,…
-
Angle of injection and whether 90 degrees is always right Replied, post #50 · Practice › Administration · 14 Nov 2025 · 29 likes Pinch or no pinch: the decision depends on needle length and on your own anatomy. A longer needle (8 mm and up) reaches subcutaneous tissue easily without a pinch. A…
-
How to read a forest plot, properly, from scratch Replied, post #54 · Evidence › Trials · 12 Nov 2025 · 1 like Generalisability: the enrolled population was selected in ways that matter. Entry criteria, run-in periods, and the simple fact that people who agree to a multi-year…
-
Cost per delivered dose, which is the number that matters Replied, post #21 · Access › Pricing · 11 Nov 2025 · 0 likes I read post #19 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #14 · Pharmacology › Pharmacokinetics · 5 Nov 2025 · 0 likes Worth separating two things that post #10 runs together. Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds, volume…
-
Prescription requirements and telehealth models Started this topic · Sourcing › Regulatory · 3 Nov 2025 · 5 likes Prescription requirements and telehealth models Writing it up because I had to work it out twice and would rather nobody else did. A logistics question, since the…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #86 · Safety › Adverse events · 3 Nov 2025 · 6 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
What a purity-only report leaves out Replied, post #61 · Sourcing › Independent verification · 26 Oct 2025 · 0 likes VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials. Tells you something about a supplier's systems but says nothing…
-
[2026 update] A single out-of-range value on an otherwise normal panel Replied, post #17 · Clinical › Bloodwork · 22 Oct 2025 · 15 likes I read post #15 twice before replying, because I had assumed the opposite. HbA1c and glucose: HbA1c reflects average glucose over months; a spot glucose measurement…
-
Why oral semaglutide needs an absorption enhancer at all Replied, post #43 · Compounds › Oral incretins · 21 Oct 2025 · 9 likes Worth separating two things that post #39 runs together. Why administration conditions matter for oral semaglutide and not for injectables: the oral formulation depends…
-
An orphaned page with no inbound links — the long version Replied, post #12 · Meta › Wiki maintenance · 10 Oct 2025 · 6 likes This follows post #9 rather than contradicting it. Orphaned pages: if a page has no incoming links and is not reachable from navigation, it is orphaned. Such pages…
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #100 · Analytics › HPLC & UHPLC · 9 Oct 2025 · 19 likes Picking up post #97: that is the part I would want checked first. Gradient slope is the single biggest driver of apparent purity differences. A shallower gradient over…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #46 · Analytics › COA interpretation · 4 Oct 2025 · 7 likes A certificate of analysis is a statement by its issuer that a defined test was performed on a defined lot and produced a defined result. That is all it is, and it is…
-
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #51 · Compounds › Secretagogues & GH axis · 24 Sep 2025 · 8 likes Development history is more informative than speculation: ipamorelin was investigated clinically for post-operative ileus and was not taken forward to registration.…
-
Hypertension improvement and when medication needs revisiting Replied, post #66 · Clinical › Comorbidities · 17 Sep 2025 · 0 likes PCOS and metabolic overlap: polycystic ovary syndrome has metabolic overlap with obesity and insulin resistance. Data on compounds in this class in PCOS specifically is…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #16 · Practice › Storage & stability · 28 Aug 2025 · 6 likes Beyond-use dating: the date after which a prepared solution should not be used. It is an estimate based on how fast the solution degrades under stated storage, not on…
-
Thyroid function tests during substantial weight change Replied, post #43 · Clinical › Bloodwork · 27 Aug 2025 · 0 likes This follows post #40 rather than contradicting it. TSH and free hormones: TSH is a reasonable screening test but does not tell you about actual free hormone levels. If…
-
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #28 · Pharmacology › Receptor biology · 17 Aug 2025 · 0 likes Amylin receptor signalling: amylin promotes satiety and slows gastric emptying through a receptor distinct from GLP-1. The hypothesis behind combination therapy is two…
-
What a regulator's shortage notice actually authorises — what changed since Replied, post #2 · Sourcing › Regulatory · 8 Aug 2025 · 15 likes Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is not on the market under specific conditions. The conditions are strict…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #3 · Clinical › Special populations · 24 Jul 2025 · 19 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Coming back to: Official shortage notices and what they authorise Replied, post #46 · Access › Shortages · 2 Jul 2025 · 2 likes Resuming after a gap: after a gap of days or a few weeks, most people resume at the dose they were on when they stopped. Gaps of months might require retitration…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #140 · Evidence › Journal club · 18 Jun 2025 · 1 like I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #79 · Nutrition & Training › Protein & intake · 13 Jun 2025 · 29 likes Meeting protein targets on suppressed appetite: this is where the practical difficulty lies. Eating more protein when appetite is suppressed is genuinely hard.…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #82 · Access › Insurance & coverage · 12 Jun 2025 · 0 likes Worth separating two things that post #78 runs together. Appeals process: unemotional prose, the criterion quoted verbatim, evidence mapped to it point by point, dates,…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #78 · Data & Tools › Calculators · 19 May 2025 · 21 likes Units: all calculators explicitly require units to be stated. This prevents the decimal-point errors that come from forgetting units. Always verify units in and out.
-
Second pass at: Designing a personal experiment that could change your mind Replied, post #21 · Research Methods › N-of-1 designs · 19 May 2025 · 1 like On post #17 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Why plausible mechanism is not evidence of effect — one year on Replied, post #3 · Compounds › Repair & healing peptides · 11 May 2025 · 1 like TB-500 is usually the 7-residue actin-binding fragment of thymosin beta-4, not the full 43-residue protein. The two are routinely conflated in supplier documentation…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #22 · Outcomes › Body composition · 9 May 2025 · 11 likes Changes during titration: measuring body composition during active titration is less useful than measuring after dose is stable. Titration causes fluid shifts that…
-
Follow-up: What other technical communities get right that we do not Replied, post #92 · Lounge › Off topic · 9 May 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #44 · Sourcing › Independent verification · 3 May 2025 · 0 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
Follow-up: Documentation that appears only after payment Replied, post #34 · Sourcing › Red flags · 30 Apr 2025 · 10 likes This follows post #31 rather than contradicting it. Inconsistency across documents: a certificate stating one purity, a website claiming another, and a supplier's…
-
Metformin co-administration and additive GI effects Replied, post #11 · Practice › Interactions · 23 Apr 2025 · 1 like Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Publishing an inconvenient result: a case study Replied, post #11 · Sourcing › Independent verification · 23 Apr 2025 · 0 likes Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter verification records are assessments maintained over time.…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #54 · Practice › Reconstitution · 20 Apr 2025 · 0 likes post #53 is right about the mechanism and I think understates the practical bit. Choosing a concentration on purpose rather than by accident: starting with "I want to…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #43 · Evidence › Journal club · 19 Apr 2025 · 9 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
-
Retatrutide dose escalation in the published trials Replied, post #147 · Compounds › Retatrutide · 18 Apr 2025 · 18 likes I read post #145 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Fibre intake when total intake falls, and the constipation link Replied, post #45 · Nutrition & Training › Protein & intake · 26 Mar 2025 · 0 likes Fibre: adequate fibre intake supports fullness and gut motility, both of which matter during the gastrointestinal effects of these compounds. High fibre on top of…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #128 · Compounds › Semaglutide · 14 Mar 2025 · 1 like post #127 is right about the mechanism and I think understates the practical bit. The STEP programme populations were selected: enrollment criteria required baseline…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #59 · Analytics › COA interpretation · 8 Mar 2025 · 29 likes Sterility testing is separate: chromatographic purity, mass spectrometry, and endotoxin testing all say nothing about whether a solution is sterile. If sterility…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #33 · Compounds › Tirzepatide · 5 Mar 2025 · 2 likes Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that means steady state is reached slightly faster and the post-dose…
-
Consistent declarations and why they matter more than clever ones Replied, post #16 · Sourcing › Logistics · 10 Feb 2025 · 0 likes Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…
-
What we do not know about retatrutide, listed explicitly Replied, post #75 · Compounds › Retatrutide · 30 Jan 2025 · 20 likes post #74 is right about the mechanism and I think understates the practical bit. What we do not know about retatrutide, listed explicitly: long-term safety, real-world…
-
Escalating every six weeks instead of four: what I observed over eight months Replied, post #19 · Practice › Dosing & titration · 14 Jan 2025 · 0 likes post #18 answers the question as asked. The question underneath it is different. Stepping down deliberately: the withdrawal trials show that stopping is followed by…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #81 · Compounds › Semaglutide · 24 Dec 2024 · 0 likes post #80 answers the question as asked. The question underneath it is different. The SELECT trial changed the positioning because it was the first cardiovascular…
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #78 · Devices › Syringes & needles · 7 Dec 2024 · 20 likes Coming back to post #76, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #138 · Analytics › COA interpretation · 3 Dec 2024 · 5 likes Picking up post #135: that is the part I would want checked first. What fields matter on a certificate: lot number matching the vial, test date, the analytical method…
-
Isotope patterns and why the monoisotopic peak is not the tallest Replied, post #4 · Analytics › Mass spectrometry · 27 Nov 2024 · 32 likes post #3 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #37 · Evidence › Journal club · 20 Nov 2024 · 0 likes post #36 is right about the mechanism and I think understates the practical bit. Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the…
-
Time to steady state after a dose increase Replied, post #82 · Pharmacology › Pharmacokinetics · 4 Nov 2024 · 21 likes Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The half-life determines how much accumulation happens at steady…
-
Why "any advice?" is the least effective ending for a post Replied, post #8 · Start Here › How to Ask · 4 Nov 2024 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Requesting a page: what makes a good request — what changed since Replied, post #130 · Documentation › Wiki requests · 13 Oct 2024 · 0 likes This follows post #127 rather than contradicting it. Request a new maintained page: if a question recurs, has a good marked solution, and contains a worked example, it…
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #18 · Evidence › Journal club · 16 Aug 2024 · 0 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
Cold packs, phase-change material, and what survives ten days Replied, post #112 · Sourcing › Logistics · 16 Jul 2024 · 5 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.